GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Exhibits Superior Anti-Tumor Efficacy and Superior Tissue B Cell Depletion In Vivo.

抗体依赖性细胞介导的细胞毒性 表位 CD20 抗体 CD19 单克隆抗体 B细胞 化学 分子生物学 免疫学 生物
作者
Pablo Umaña,Ekkehard Moessner,Peter Bruenker,Klingner Gabriele,Ursula Püentener,Tobias Suter,Roger Grau,Carla Schmidt,Sylvia Herter,Christian Gerdes,Adam Nopora,Monika Patre,Samuel Moser,Peter Sondermann,Luise Wheat,Martin J.S. Dyer,Sibrand Poppema,Sabine Bauer,Manfred Kubbies,Pamela Strein
出处
期刊:Blood [Elsevier BV]
卷期号:110 (11): 2348-2348 被引量:22
标识
DOI:10.1182/blood.v110.11.2348.2348
摘要

Abstract GA101 is a novel monoclonal antibody of IgG1 type which binds with high affinity and selectivity to the extracellular domain of the human CD20 antigen on B cells. In contrast to rituximab which is a chimeric antibody and recognizes a type I epitope, GA101 is humanized and recognizes a type II epitope which is also localized in the extracellular loop of CD20. The recognition of the type II epitope together with a modification of the elbow hinge region results in enhanced direct non-caspase dependent cell death induction, and concomitant reduction in CDC upon binding to CD20. In addition, using GlycoMab technology, the Fc-region of GA101 was glycoengineered to contain bisected, afucosylated carbohydrates. As a result GA101 has increased affinity for the low and high affinity FcγRIIIa receptor expressed on natural killer cells, macrophages and monocytes. Consequently, GA101 mediated a 5–50 fold enhanced induction of effector cell mediated ADCC. In B-cell depletion assays with whole blood from healthy donors, an assay combining all mechanisms of action, GA101 was significantly more potent and efficacious in depleting B cells than rituximab. In preclinical NHL testing these properties translated into superior anti-tumoral efficacy of GA101 in direct comparison to rituximab against a number of aggressive NHL xenograft models. In cynomolgus monkeys the induction of B cell depletion mediated by GA101 and subsequent B cell recovery were investigated. GA101 induced complete, rapid and long-lasting B cell depletion both in peripheral blood and in lymphoid tissue e.g. spleen and lymph nodes. The efficacy of GA101 (10 and 30 mg/kg) at depleting B cells in different lymphoid tissues of cynomolgus monkeys was compared with that of rituximab (10 mg/kg) following 2 i.v. doses administered on days 0 and 7. Notably, GA101 showed statistically superior depletion of total B cells from lymph nodes compared to Rituximab from day 9 to 35 onwards with B cell numbers decreased by over 95%. These results demonstrated that GA101 was more efficacious at depleting B cells from lymph nodes and spleen of cynomolgus monkeys compared to rituximab. Compared to existing antibodies, GA101 constitutes the first type II CD20 antibody engineered for increased ADCC with significantly enhanced efficacy in a variety of preclinical models. Based on these data it is assumed that the combination of the recognition of a type II epitope together with improved ADCC potency might translate into superior efficacy in the clinical treatment of CD20 positive malignant diseases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
学术小白发布了新的文献求助10
刚刚
1秒前
wsy完成签到,获得积分10
1秒前
peir完成签到,获得积分10
2秒前
科研努力版完成签到 ,获得积分10
3秒前
风吹麦浪发布了新的文献求助10
3秒前
4秒前
小二郎的应助被嗷嗷ao采纳,获得10
4秒前
欧阳峰发布了新的文献求助10
4秒前
宋宋完成签到 ,获得积分10
6秒前
6秒前
7秒前
水煮电吹风的应助被剪刀手采纳,获得10
7秒前
大碗完成签到,获得积分10
8秒前
9秒前
CAOHOU的应助被吱吱采纳,获得10
9秒前
欧阳峰完成签到,获得积分10
9秒前
10秒前
10秒前
1618完成签到 ,获得积分10
10秒前
Ning_完成签到,获得积分10
10秒前
一只鱼完成签到 ,获得积分10
10秒前
11秒前
zivi完成签到,获得积分20
11秒前
易宋发布了新的文献求助10
11秒前
Owen的应助被惠1采纳,获得10
11秒前
meimei完成签到 ,获得积分10
12秒前
和道一文字完成签到,获得积分10
13秒前
kiiso发布了新的文献求助10
15秒前
15秒前
江枫渔火完成签到 ,获得积分0
16秒前
tang发布了新的文献求助10
16秒前
Juvenilesy的应助被墨尘采纳,获得10
16秒前
pmh完成签到,获得积分10
18秒前
和谐完成签到 ,获得积分10
18秒前
D_DAY完成签到,获得积分10
19秒前
20秒前
20秒前
20秒前
hudirudi完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621